Abstract
Mass Spectrometry Imaging (MSI) has evolved into a valuable tool for research into and the diagnosis of disease pathology. The ability to perform multiplex analysis of a wide range of molecules (e.g., proteins, lipids, and metabolites) simultaneously per tissue section while retaining the histological structure of the sample allows molecular information and tissue morphology to be correlated, thus increasing our understanding of a particular disease. Further development of MSI is required to improve suitability to the alternative models available, so that the combined approach can successfully provide the information required in disease characterization and prevention. MSI has been shown to be capable of providing spatiomolecular information in tumor spheroids, living skin equivalents, and ex vivo human tissues. Due to a considerable interest and scientific effort there are many more designed alternative disease models available which would benefit from the information MSI could provide.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cole LM et al (2011) Investigation of protein induction in tumour vascular targeted strategies by MALDI MSI. Methods 54(4):442–453
Reis-Filho JS, Lakhani SR (2008) Breast cancer special types: why bother? J Pathol 216(4):394–398
Vargo-Gogola T, Rosen JM (2007) Modelling breast cancer: one size does not fit all. Nat Rev Cancer 7(9):659–672
Guenther S et al (2015) Spatially resolved metabolic phenotyping of breast cancer by desorption electrospray ionization mass spectrometry. Cancer Res 75(9):1828–1837
Mao X et al (2016) Application of imaging mass spectrometry for the molecular diagnosis of human breast tumors. Sci Rep 6:21043
Attia AS et al (2012) Monitoring the inflammatory response to infection through the integration of MALDI IMS and MRI. Cell Host Microbe 11(6):664–673
Steu S et al (2008) A procedure for tissue freezing and processing applicable to both intra-operative frozen section diagnosis and tissue banking in surgical pathology. Virchows Arch 452(3):305–312
Seeley EH, Caprioli RM (2011) MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives. Trends Biotechnol 29(3):136–143
Fox CH et al (1985) Formaldehyde fixation. J Histochem Cytochem 33(8):845–853
Westermark P, Nilsson GT (1984) Demonstration of amyloid protein AA in old museum specimens. Arch Pathol Lab Med 108(3):217–219
Battifora H (1986) The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab Invest 55(2):244–248
Battifora H, Mehta P (1990) The checkerboard tissue block. An improved multitissue control block. Lab Invest 63(5):722–724
Groseclose MR et al (2008) High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics 8(18):3715–3724
Djidja M-C et al (2010) Novel molecular tumour classification using MALDI-mass spectrometry imaging of tissue micro-array. Anal Bioanal Chem 397(2):587–601
Buck A et al (2015) High-resolution MALDI-FT-ICR MS imaging for the analysis of metabolites from formalin-fixed, paraffin-embedded clinical tissue samples. J Pathol 237(1):123–132
Li M, Fan P, Wang Y (2015) Lipidomics in health and diseases - beyond the analysis of lipids. J Glycomics Lipidomics 05(01):126
Renshaw S (2007) Immunochemical staining techniques. In: Renshaw S (ed) Immunohistochemistry: methods express. Scion Publishing Ltd, Bloxham, pp 45–96
Greek R, Menache A (2013) Systematic reviews of animal models: methodology versus epistemology. Int J Med Sci 10(3):206–221
Stranger BE, Stahl EA, Raj T (2011) Progress and promise of genome-wide association studies for human complex trait genetics. Genetics 187(2):367–383
Shanks N, Greek R, Greek J (2009) Are animal models predictive for humans? Philos Ethics Humanit Med 4(1):2
Mead B et al (2016) Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma. Cytotherapy 18(4):487–496
Tamaki C et al (2013) Potentials and limitations of nonclinical safety assessment for predicting clinical adverse drug reactions: correlation analysis of 142 approved drugs in Japan. J Toxicol Sci 38(4):581–598
van Meer PJ et al (2012) The ability of animal studies to detect serious post marketing adverse events is limited. Regul Toxicol Pharmacol 64(3):345–349
Alnasif N (2014) Penetration of normal, damaged and diseased skin--an in vitro study on dendritic core-multishell nanotransporters. J Control Release 185:45–50
Choi SH et al (2014) A three-dimensional human neural cell culture model of Alzheimer’s disease. Nature 515(7526):274–278
Rodenhizer D et al (2015) A three-dimensional engineered tumour for spatial snapshot analysis of cell metabolism and phenotype in hypoxic gradients. Nat Mater 15:227–234
Kappler B et al (2016) The cytoprotective capacity of processed human cardiac extracellular matrix. Materials in. Medicine 27(120):1–13
Li H, Hummon AB (2011) Imaging mass spectrometry of three-dimensional cell culture systems. Anal Chem 83(22):8794–8801
LaBonia GJ et al (2016) Drug penetration and metabolism in 3D cell cultures treated in a 3D printed fluidic device: assessment of irinotecan via MALDI imaging mass spectrometry. Proteomics 16(11–12):1814–1821
European Commission (2009) Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products
Mitchell CA et al (2015) Lipid changes within the epidermis of living skin equivalents observed across a time-course by MALDI-MS imaging and profiling. Lipids Health Dis 14(1):84
Harvey A et al (2016) MALDI-MSI for the analysis of a 3D tissue-engineered psoriatic skin model. Proteomics 16(11–12):1718–1725
Niehoff A-C et al (2014) A palladium label to monitor nanoparticle-assisted drug delivery of a photosensitizer into tumor spheroids by elemental bioimaging. Metallomics 6(1):77–81
Niehoff A-C et al (2016) Quantitative bioimaging of platinum group elements in tumor spheroids. Anal Chim Acta 938:106–113
Hart PJ et al (2013) Matrix assisted laser desorption ionisation ion mobility separation mass spectrometry imaging of ex-vivo human skin. Int J Ion Mobil Spectrom 16(2):71–83
Kezutyte T et al (2013) Studying the penetration of fatty acids into human skin by ex vivo TOF-SIMS imaging. Biointerphases 8(1):3
Passarelli MK et al (2015) Single-cell analysis: visualizing pharmaceutical and metabolite uptake in cells with label-free 3D mass spectrometry imaging. Anal Chem 87(13):6696–6702
Fennema E et al (2013) Spheroid culture as a tool for creating 3D complex tissues. Trends Biotechnol 31(2):108–115
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Day, R.E., Palubeckaite, I. (2017). The Future in Disease Models for Mass Spectrometry Imaging, Ethical Issues, and the Way Forward. In: Cole, L. (eds) Imaging Mass Spectrometry . Methods in Molecular Biology, vol 1618. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7051-3_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7051-3_16
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7050-6
Online ISBN: 978-1-4939-7051-3
eBook Packages: Springer Protocols